NHS England is to fund a life changing treatment for thousands of people with severe Haemophilia, which will dramatically cut their risk of life-threatening bleeds and reduce treatment time. The new treatment is part of a package of measures set out in the NHS Long Term Plan which will save lives through access to the […]
People living with brain and nerve conditions like Parkinson’s could benefit from quicker diagnosis and better coordinated care as part of a new NHS initiative, which is also set to free up millions of pounds to reinvest in patient care. NHS experts have joined forces with seven leading charities to produce a toolkit that will […]
NHS England will provide a promising new treatment which can prolong the lives of children with a rare genetic condition after negotiating a deal with the manufacturer. Nusinersen, also called Spinraza and made by Biogen, is the first treatment that targets the underlying cause of spinal muscular atrophy (SMA). The condition affects the nerves in […]
New places for the PrEP Impact Trial will now start to be released following agreement at the PrEP Oversight Board. Implementation of the PrEP Impact trial has been a huge success with over 11,500 participants already enrolled in this important HIV prevention measure. With the speed of recruitment and need for PrEP significantly exceeding initial […]
Implementation of the PrEP Impact trial has been a huge success with over 10,000 participants already enrolled in this important HIV prevention measure. But, the speed of recruitment and demand for PrEP has significantly exceeded initial expert predictions and the trial researchers now consider that more places should be made available. They argue that recruitment […]
Local health services today are being allocated £570 billion to fund NHS services and implement the new long term plan. Every area in England will receive a cash increase of at least 17% over the next five years, including a minimum rise of 4.4% next year. Some £1 billion a year will be distributed according […]
The NHS is set to save a record £300 million after negotiating deals with five manufacturers on low cost versions of the health service’s most costly drug, Simon Stevens announced today. The huge anticipated saving, the biggest in NHS history from a single drug negotiation, was unlocked by the introduction of ‘biosimilar’ versions of adalimumab […]
Adult cancer patients in England will receive a new game-changing therapy treatment under the first negotiated deal of its kind struck in Europe, NHS England chief executive Simon Stevens announced today. This is the first time adult NHS patients will have access to CAR-T, and follows a deal NHS England reached last month to make […]
Stroke-reducing heart implants and a life changing surgical procedure for children with cerebral palsy are among a host of new treatments that will now be routinely available for thousands of patients on the NHS. The NHS announced its plan to provide the latest innovative treatments for patients, just days after it celebrated its 70th anniversary. Hundreds […]
NHS chief Simon Stevens has today announced that NHS England has struck a deal with MSD, endorsed by NICE, to make the lung cancer drug pembrolizumab available for routine use on the NHS. New trial results show pembrolizumab extends life for certain adults with lung cancer for more than a year. Pembrolizumab is the first […]